CATHERINE MONTGOMERY: Open Payments
NPI 1497792964 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,525 in 115 payments from 22 companies in 2025. Trend: 2023 $1,959 · 2024 $2,383 · 2025 $2,525
Food & beverage: $2,525
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 21 | $643 |
| Gilead Sciences, Inc. | 21 | $445 |
| AstraZeneca Pharmaceuticals LP | 6 | $210 |
| ABBVIE INC. | 16 | $204 |
| Novo Nordisk Inc | 9 | $150 |
| Merck Sharp & Dohme LLC | 6 | $134 |
| Abbott Laboratories | 5 | $118 |
| Corcept Therapeutics | 3 | $85 |
| Amgen Inc. | 5 | $84 |
| Sumitomo Pharma America, Inc. | 3 | $80 |
Products named: DOVATO, AIRSUPRA, APRETUDE, PIFELTRO, Yeztugo, QULIPTA, Korlym, CABENUVA.
Industry payments across AZ — which companies pay providers there.
